Combination anti-HIV antibodies to achieve antiretroviral therapy-free virological suppression in infected individuals
- PMID: 36101965
- PMCID: PMC9471046
- DOI: 10.1002/ctm2.1057
Combination anti-HIV antibodies to achieve antiretroviral therapy-free virological suppression in infected individuals
Conflict of interest statement
The authors have declared no conflict of interest exists.
Comment on
-
Prolonged viral suppression with anti-HIV-1 antibody therapy.Nature. 2022 Jun;606(7913):368-374. doi: 10.1038/s41586-022-04597-1. Epub 2022 Apr 13. Nature. 2022. PMID: 35418681 Free PMC article.
-
Combination anti-HIV antibodies provide sustained virological suppression.Nature. 2022 Jun;606(7913):375-381. doi: 10.1038/s41586-022-04797-9. Epub 2022 Jun 1. Nature. 2022. PMID: 35650437 Free PMC article. Clinical Trial.
References
-
- Danforth K, Granich R, Wiedeman D, Baxi S, Padian N. Global mortality and morbidity of HIV/AIDS. Major Infectious Diseases; 2017. - PubMed
-
- Chun TW, Moir S, Fauci AS, HIV reservoirs as obstacles and opportunities for an HIV cure. Nat Immunol. 2015;16(6):584‐589. - PubMed
-
- Chun TW, Eisinger RW, Fauci AS, Durable control of HIV infection in the absence of antiretroviral therapy: opportunities and obstacles. JAMA. 2019;322(1):27‐28. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical